StockWatch
·
Biotechnology: Pharmaceutical Preparations
RegulatoryJun 1, 2026, 03:30 PM

Exicure receives Nasdaq delinquency notice, regains compliance after 10-Q filing

AI Summary

Exicure, Inc. received a Nasdaq notification on May 28, 2026, for non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. The delay was attributed to changes in financial reporting personnel and procedures. The company subsequently filed the Form 10-Q on May 29, 2026, and believes it has regained compliance with Nasdaq's listing requirements.

Key Highlights

  • Exicure received a Nasdaq delinquency notice on May 28, 2026.
  • The notice cited non-compliance with Listing Rule 5250(c)(1) for delayed Q1 2026 10-Q filing.
  • The delay was due to changes in financial reporting personnel and procedures.
  • Exicure filed its Q1 2026 Form 10-Q with the SEC on May 29, 2026.
  • The company believes it has regained compliance with Nasdaq listing rules.